Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BNGO · as of Mar 31, 2025
Ownership Breakdown
31
Institutional Holders
▼ 18 vs Q4
$416,006
Total Inst. Value
▼ $1.28M vs Q4
3.28M
Shares Outstanding
freeFloat 99.64%
149,106
13F Shares Held
▼ 5.73M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BNGO largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC laboratory analytical instruments | 50.0K | 1.86% | 1.86% | $139.44M | May 9, 2025 | NEW |
EVERSTAR ASSET MANAGEMENT, LLC laboratory analytical instruments | 45.0K | 1.67% | 1.67% | $957.71M | May 16, 2025 | NEW |
SUSQUEHANNA INTERNATIONAL GROUP, LLP laboratory analytical instruments | 17.5K | 64.96% | 64.96% | $48.83M | May 14, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC laboratory analytical instruments | 15.5K | 57.56% | 57.56% | $43.27M | May 13, 2025 | NEW |
MORGAN STANLEY laboratory analytical instruments | 12.0K | 44.51% | 44.51% | $33.45M | May 15, 2025 | NEW |
BLACKROCK, INC. laboratory analytical instruments | 10.1K | 37.50% | 37.50% | $28.19M | May 2, 2025 | NEW |
BANK OF AMERICA CORP /DE/ laboratory analytical instruments | 8.4K | 31.15% | 31.15% | $23.42M | May 15, 2025 | NEW |
ADVISOR GROUP HOLDINGS, INC. laboratory analytical instruments | 3.2K | 11.91% | 11.91% | $8.95M | May 12, 2025 | NEW |
UBS GROUP AG laboratory analytical instruments | 2.4K | 8.81% | 8.81% | $6.62M | May 13, 2025 | NEW |
GROUP ONE TRADING, L.P. laboratory analytical instruments | 1.8K | 6.64% | 6.64% | $4.99M | May 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares29
New Positions
first time holders2
Decreased
−9.1K shares19
Sold Out
fully exitedNet shares change (top 50)
9.1K
+0 / −9.1K
Net new holders
+8
29 new / 19 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BNGO insider trading · insider activity
Source: SEC Form 4
5
Buy transactions
4
Sell transactions
1.25
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Dixon Jonathan V. GENERAL COUNSEL | Jun 3, 2026 | Tax Withhold | 24 | $1.30 | $31.2 | 239 | Form 4 ↗ |
OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Jun 3, 2026 | Tax Withhold | 27 | $1.30 | $35.1 | 868 | Form 4 ↗ |
Chaubey Alka CHIEF MEDICAL OFFICER | Jun 3, 2026 | Tax Withhold | 24 | $1.30 | $31.2 | 620 | Form 4 ↗ |
Adamchak Mark Principal Accounting Officer | Jun 3, 2026 | Tax Withhold | 7 | $1.30 | $9.1 | 253 | Form 4 ↗ |
Rajkovic Aleksandar director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Linney Yvonne director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Vuori Kristiina MD director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
TWOMEY CHRISTOPHER J director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
BARKER DAVID L director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Chaubey Alka CHIEF MEDICAL OFFICER | Feb 17, 2026 | Tax Withhold | 18 | $1.10 | $19.8 | 644 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bionano Genomics, Inc. (BNGO) is primarily owned by institutional investors, who hold approximately 4.5% of total shares outstanding. Company insiders own approximately 0.36%, while retail and public investors account for the remaining 95.10%.
The largest institutional shareholder of Bionano Genomics, Inc. is VANGUARD GROUP INC, holding approximately 49,979 shares — equal to 1.86% of outstanding shares — as of March 31, 2025.
A total of 31 institutional investors currently hold BNGO stock, with a combined institutional value of approximately $416,006 as of the most recent 13F filing period.
Frequently asked questions
BNGO ownershipBionano Genomics, Inc. (BNGO) is primarily owned by institutional investors, who hold approximately 4.5% of shares. The largest shareholder is VANGUARD GROUP INC with a 1.86% stake. Company insiders hold 0.36%. Data sourced from SEC Form 13F as of March 31, 2025.